Biomarkers for the Brain
ArticlesDrug Discovery and DevelopmentFeatured Stories

Biomarkers for the Brain

Frost & Sullivan, a business consulting firm involved in market research and analysis, conducted a thought leadership forum that brought together experts in the field of CNS biomarkers. Follow their discussions about technological advancements in the field and future implications of the current research and development.
READ MORE →
Brilliant Science Podcast
ArticlesDrug Discovery and DevelopmentPodcasts

Brilliant Science Podcast Series

The Brilliant Science podcasts will introduce you to some of the amazing science being done around the world. Join us every month to see what you can learn.
READ MORE →
Alzheimer’s Disease: A Smoking Gun with No Suspect
ArticlesDrug Discovery and DevelopmentFeatured Stories

Alzheimer’s Disease: A Smoking Gun with No Suspect

For the past 30 years, there has been one assumed culprit of Alzheimer’s disease (AD) — beta-amyloid. However, researchers have been unsuccessful in developing effective therapies targeting this protein. Understand the history of AD and beta-amyloid and see what other biomarkers are being investigated as potential therapeutic targets.
READ MORE →
Novel Biomarkers for Traumatic Brain Injury
ArticlesDrug Discovery and DevelopmentFeatured Stories

Traumatic Brain Injury — A Controversial and Deadly Epidemic

Ever wonder how football is linked to degenerative brain disease? Find out here. Also, learn about novel biomarkers for traumatic brain injury (TBI), the current state of TBI research, and promising new approaches for developing a robust diagnostic tool. Discover tests currently used to diagnose TBI and read about unusual techniques used to develop reliable biomarkers.
READ MORE →
R-Loops in Cancer Research
ArticlesCell BiologyDrug Discovery and Development

R-Loops and Their Key Role in Cancer Research

R-loops are being investigated as potential therapeutic targets for cancer. Find out what they are, how they form, how their formation is controlled by our cells, and, above all, their potential as therapeutic targets.
READ MORE →
Bioinformatics and Our Microbiome
ArticlesDrug Discovery and DevelopmentPodcasts

Say Hello to Your Littlest Friends — the Microbiota

How well do you understand your microbiota? Dr. Allyson Byrd of Genentech, the fourth guest on Brilliant Science, is a bioinformatician focusing on parsing all the data our microbiomes have to offer. Read about the value of analyzing microbiota and how Dr. Byrd hopes to leverage the results.
READ MORE →
Single-Cell Analysis and the Endless Possibilities
ArticlesDrug Discovery and DevelopmentPodcasts

Finding New Horizons — What Possibilities Exist with Single-Cell Analysis?

Single-cell techniques offer exciting, new ways to understand personalized medicine and research. Developing these techniques at Bio-Rad is Dr. Kelly Kaihara, the third guest on Brilliant Science. Read about what makes single-cell analysis different and Kaihara’s perspective on its potential moving forward.
READ MORE →
Benefits of Flow Cytometry in Immuno-Oncology Research
ArticlesCell BiologyDrug Discovery and DevelopmentFeatured Stories

The Benefits of Flow Cytometry in Immuno-Oncology Research

Immuno-oncology, or cancer immunotherapy, research focuses heavily on the various types of cells and their behavior in cancer, so the use of flow cytometry to interrogate these cells is a no brainer. See how flow cytometry fits in this growing field of research and how it can help identify new targets and improve drug design to generate more effective and safer cancer therapeutics.
READ MORE →
Phagocytosis and Phasing Out Disease
ArticlesDrug Discovery and DevelopmentPodcasts

Phagocytosis and Phasing Out Disease

Our immune systems could soon hold the key to rewriting disease and disorder treatments. Studying the inner workings of the immune system’s primary weapon, the macrophage, with the help of CRISPR is Dr. Adam Hoppe at SDSU. Read more about his exciting work and what he hopes to accomplish next.
READ MORE →
The Potential for CRISPR Gene Editing in HIV
ArticlesDrug Discovery and DevelopmentFeatured Stories

The Potential for CRISPR Gene Editing in HIV

The advent of CRISPR as a gene editing tool appears to have revolutionized drug discovery and development in a very short time. CRISPR-Cas9 technology is also being utilized to target HIV, to mutate or cut out the provirus. Read about what’s new in potential treatments for HIV and the challenges facing the industry.
READ MORE →